Skip to main content

Table 1 Clinicopathological and laboratory characteristics of patients with NSCLC

From: Clinical significance of HRAS and KRAS genes expression in patients with non–small-cell lung cancer - preliminary findings

Parameter

N

%

Median

Range

Total

39

   

Sex

    

 Male

32

82

  

 Female

7

18

  

Smoking

    

 Smoker

25

64

  

 Non-smoker

14

36

  

Histological type of cancer

    

 Adenocarcinoma

16

41

  

 Squamous cell carcinoma

23

59

  

Grade of histological malignancy [G]

    

 G1

3

8

  

 G2

29

74

  

 G3

8

21

  

TNM stage

    

 IA1

1

3

  

 IA2

7

18

  

 IB

11

28

  

 IIA

7

18

  

 IIB

5

13

  

 IIIA

8

21

  

Chemotherapy

    

 No

26

66.6

  

 Yes

13

33.3

  

WBC (× 109/l)

  

9.65

6.02–19.39

RBC (× 1012/l)

  

4.61

3.54–5.84

PLT (×109/l)

  

299

167–961

NLR

  

3.88

0.97–20.39

LMR

  

2.2

0.62–5.87

PLR

  

154

61–976

  1. Abbreviations: NLR Neutrophil to Lymphocyte Ratio, LMR Lymphocyte to Monocyte Ratio, PLR Platelet to Lymphocyte Ratio, TNM Tumor-node-metastasis, WBC White blood cells, RBC Red blood cells, PLT Platelets
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us